Please note the HSE Cross Border Directive can not be used to access drug therapies that are currently not provided for in the public healthcare system in Ireland or to access clinical trials abroad
The HSE operates a Cross-Border Healthcare Directive (CBD), for people entitled to public patient healthcare in Ireland who want to avail of that healthcare in another EU/EEA* member state under Directive 201/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patient’s rights in cross-border healthcare, as per the procedures set out in governing EU Regulations and Directives and Irish legislation. A private outpatient appointment in the Republic of Ireland may not be used under any circumstances to exercise rights for the purposes of reimbursement under the provisions of the Cross Border Healthcare Directive. The attendance of a private appointment in Ireland deems the patient a private patient and not a public patient for the purpose of provisions the Cross Border Directive.
Please ensure that you have taken out appropriate insurance while travelling abroad including outlining to your insurer that you are travelling abroad to obtain health treatment.
*Switzerland have yet to complete the process to have the Directive apply to them.
It is free to apply for the HSE Cross Border Healthcare Directive. Anyone asking for money is not connected with the HSE.
Important update - June 2019
The HSE’s list of DRG codes and associated cost/reimbursement rates has been updated.
Inpatient treatment costs in Ireland are now set out in a document called the 'Admitted Patient Price List Summary (Inpatient)' (PDF, 1.39mb,32 pages).
Day case treatment costs in Ireland are now set out in a document called the 'Admitted Patient Price List Summary (Day case)' (PDF, 821kb,15 pages).
Use this document to find out the maximum amount you can reclaim for treatment abroad.
These documents have been in effect since 1 June 2019. All treatments received from the 1st June 2019 onwards will be reimbursed in line with the updated lists.
Previous to that a document called the 'ready reckoner' was used. If a patient can demonstrate that he/she scheduled his/her treatment prior to the 1st June 2019, and wishes to be reimbursed at the previous rate we will consider same.
In such instances the patient will be required to submit the original appointment letter which must be dated prior to 1st June 2019.
Delay in processing claims - March 2019
There is currently a delay of more than 3 months in processing applications and claims for reimbursement under the Cross Border Directive.
This is due to:
- a large number of applications and reimbursement claims
- current available staff numbers
All claims are processed in the order of the date that we received them.
We apologise for any inconvenience. We are working to resolve this matter as soon as possible.